Weight loss plateaus are common, but in many cases, the reasons are identifiable and fixable, say doctors. ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

Mounjaro was approved by the FDA in May, becoming the first combined GLP-1/GIP agonist to reach the market, ... and data on titration rates and patients stopping or not adhering to therapy, ...

Mounjaro is the third in a line of weight loss injections available in the UK, which all work by affecting hunger hormones to reduce appetite. In 2020, the first weight loss injection available in ...